Rotarix Vaccine

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Rotarix Vaccine is a live attenuated oral rotavirus vaccine. Its labelling describes it for the prevention of gastroenteritis caused by rotavirus infection in infants, given as an oral course. It is described as prompting the immune system to build protection against the rotavirus strain.

Active ingredient
Live attenuated human rotavirus (RIX4414 strain)
Dosage form
Oral suspension
Therapeutic class
Viral vaccine (active immunisation)
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with the live attenuated human rotavirus vaccine and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Described for the prevention of rotavirus gastroenteritis in infants
  • Described as given as an oral course on the schedule set by the healthcare provider
  • Described as prompting the immune system to protect against the weakened rotavirus strain
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • Administered only by a doctor or nurse as an oral dose — not self-administered
  • Given as a course of oral doses; the interval set by the doctor should be followed
  • The full course should be completed for the vaccine to work as intended, without exceeding the stated dose

Described Side Effects

Commonly described side effects include:

  • Irritability
  • Raised body temperature (fever)
  • Muscle aches and pains
  • Vomiting
  • Diarrhoea

These are described as usually short-lived. Any severe, persistent, or unexpected reaction requires prompt medical attention.

Precautions

  • The doctor should be told if the infant has a weakened immune system or a gastrointestinal disorder
  • Full medical records should be shared with the healthcare team before administration
  • Any previous allergic reaction to a vaccine or vaccine component should be disclosed beforehand
  • The vaccine should be given as instructed by the doctor, without exceeding the stated dose

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling it is a live attenuated oral rotavirus vaccine for the prevention of rotavirus gastroenteritis in infants. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.

Its labelling states it is given by a doctor or nurse as an oral dose, as a course on the schedule set by the healthcare provider. The full course should be completed as advised.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services